Cactus compositum ad us.vet.
Cactus compositum ad us.vet.
Authorised
- SELENICEREUS GRANDIFLORUS D3
- CRATAEGUS D2
- SPIGELIA ANTHELMIA D5
- KALIUM CARBONICUM D5
- NITROGLYCERINUM D5
Product identification
Medicine name:
Cactus compositum ad us.vet.
Active substance:
- SELENICEREUS GRANDIFLORUS D3
- CRATAEGUS D2
- SPIGELIA ANTHELMIA D5
- KALIUM CARBONICUM D5
- NITROGLYCERINUM D5
Target species:
-
Cattle
-
Dog
-
Goat
-
Sheep
-
Horse
-
Cat
-
Pig
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
SELENICEREUS GRANDIFLORUS D350.00milligram(s)5.00millilitre(s)
-
CRATAEGUS D250.00milligram(s)5.00millilitre(s)
-
SPIGELIA ANTHELMIA D550.00milligram(s)5.00millilitre(s)
-
KALIUM CARBONICUM D550.00milligram(s)5.00millilitre(s)
-
NITROGLYCERINUM D530.00milligram(s)5.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Homeopathic Registration
Marketing authorisation holder:
- Biologische Heilmittel Heel GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Biologische Heilmittel Heel GmbH
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 4186.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: